SCHEMBL22844793

SCHEMBL22844793

CC1OC(C(=O)O)C(O)C(O)C1OC1OC(C(=O)O)C(O)C(O)C1O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FGF2 P09038 1/20 0.40
▸ AKT1 P31749 1/20 0.39
▸ IDUA P35475 1/20 0.37
▸ ALDH1A1 P00352 2/20 0.36
▸ MAPT P10636 1/20 0.36
▸ ALOX15 P16050 1/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ GLA P06280 1/20 0.36
▸ HPGD P15428 1/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ HSD17B10 Q99714 1/20 0.36
▸ ABCC4 O15439 2/20 0.35
▸ BDNF P23560 3/20 0.35
▸ PTN P21246 2/20 0.35
▸ MDK P21741 2/20 0.35
▸ HPSE Q9Y251 2/20 0.34
▸ AMY1A P0DUB6 1/20 0.34
▸ SLCO1B1 Q9Y6L6 2/20 0.33
▸ ABCC1 P33527 1/20 0.33
▸ LMNA P02545 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24239941 1.00 FGF2 (0.40) FGF2AKT1IDUAALDH1A1MAPT
SCHEMBL13346936 0.88 AMY1A (0.38) FGF2AKT1IDUAALDH1A1MAPT
SCHEMBL22026382 0.87 IGF2R (0.48) FGF2MAPTHPSEAMY1AIGF2R
SCHEMBL30153661 0.86 FGF2 (0.37) FGF2AKT1IDUAALDH1A1MAPT
SCHEMBL23824774 0.83 FGF2 (0.41) FGF2AKT1IDUAALDH1A1KDM4E
SCHEMBL21385960 0.82 F10 (0.40) FGF2AKT1IDUAALDH1A1KDM4E
SCHEMBL16188178 0.82 F10 (0.40) FGF2AKT1IDUAALDH1A1KDM4E
SCHEMBL21233358 0.82 CD209 (0.41) FGF2ALDH1A1ALOX15MAPK1HSD17B10
SCHEMBL21233263 0.82 CD209 (0.41) FGF2ALDH1A1ALOX15MAPK1HSD17B10
SCHEMBL21030251 0.81 AKT1 (0.40) FGF2AKT1IDUAALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12043833-B2 Targeted compositions ARBUTUS BIOPHARMA CORPORATION (CA) 2024-07-23 — — US disclosed
US-20200407724-A1 TARGETED COMPOSITIONS ARBUTUS BIOPHARMA CORPORATION (CA) 2020-12-31 — — US disclosed
Send feedback